Efficacy, Safety, and Immunogenicity of a Plant-Derived Quadrivalent Virus-Like Particles (VLPs) Influenza Vaccine in Adults

Clinical trial NCT03301051 · COMPLETED

Trial details

NCT number: NCT03301051
Sponsor: Medicago
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Virus Diseases RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Influenza

Start date: 2017-08-31
Primary completion: 2018-05-02
Enrollment: 10160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.